tirzepatide phase 2 obesity Weight loss and muscle loss. The facts. GLP-1 drugs like semaglutide and produce impressive weight loss — but a consistent and underappreciated finding across trials is that a meaningful proportion of This data from Phase 3

From a pathophysiological perspective, my first thought is that this could reflect an indirect effect on peripheral nerve sensitivity, possibly related to: rapid shifts in glucoselipid metabolism, changes in nerve conduction due to electrolyte fluctuations, or even a centrally mediated effect, considering GLP-1 receptor expression in the CNS

Whether its due to the name or the clever warning, Australia and New Zealand have both decided not to carry these drinks

Diabetes, 61(2), 364371

Type 1 diabetes accounts for 5% to 10% of all cases of diabetes and is characterized by the presence of islet autoantibodies in 90% to 95% of patients